K. Datta et al., Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer, J BIOL CHEM, 275(27), 2000, pp. 20700-20706
Insulin-like growth factor-I (IGF-I)-mediated signaling is thought to be in
volved in the regulation of multiple cellular functions in different tumors
including renal cell carcinoma (RCC). Blocking IGF-I signaling by any of t
he several strategies abolishes or delays the progression of a variety of t
umors in animal models. Herein, me demonstrate that in RCC cell lines, IGF-
I-mediated signaling is found to be inhibited in the presence of wild type
von Hippel-Lindau (VHL) tumor suppresser gene. Moreover, molecular modeling
and biochemical approaches have revealed that beta-domain of the VHL gene
product by interacting directly with protein kinase C delta inhibits its as
sociation with IGF-IR for downstream signaling. We also demonstrated that R
CC has IGF-I-mediated invasive activity where protein kinase C delta is an
important downstream molecule, and this invasiveness can be blocked by wild
type VHL. These experiments thus elucidate a novel tumor suppresser functi
on of VHL with its unique kinase inhibitory domain.